Publisher： Adis International
ISSN： 1173-8324
Source： Inpharma, Vol.1, Iss.1661, 2008-01, pp. : 15-15
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Bivalirudin reduces bleeding, costs in STEMI
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 638, 2011-01 ,pp. :
Access to resources
Recommend
Bivalirudin benefit independent of GPIIb-IIIa antagonists
Inpharma, Vol. 1, Iss. 1632, 2008-01 ,pp. :
Bivalirudin: no benefit over unfractionated heparin in PCI
Inpharma, Vol. 1, Iss. 1652, 2008-01 ,pp. :
No benefit, possible harm with GIK infusion for STEMI
Reactions Weekly, Vol. 1, Iss. 1181, 2007-01 ,pp. :
No benefit, possible harm with GIK infusion for STEMI
Inpharma, Vol. 1, Iss. 1617, 2007-01 ,pp. :